Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

USMLE 1 > Microbiology- Antimicrobials > Flashcards

Microbiology- Antimicrobials Flashcards

1
Q

Antimicrobial therapy Imagen

A

Pag. 187

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Penicillin G, V

  • Mechanism
  • Clinical Use
A

Penicillin G (IV and IM form), penicillin V (oral). Prototype β-lactam antibiotics.

D-Ala-D-Ala structural analog. Bind penicillin-binding proteins (transpeptidases).

Mostly used for gram ⊕ organisms (S pneumoniae, S pyogenes, Actinomyces). Also used for gram ⊝ cocci (mainly N meningitidis) and spirochetes (namely T pallidum). Bactericidal for gram ⊕ cocci, gram ⊕ rods, gram ⊝ cocci, and spirochetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Penicillin G, V

  • Adverse effects
  • Resistance
A

Hypersensitivity reactions, direct Coombs ⊕ hemolytic anemia, drug-induced interstitial nephritis.

β-lactamase cleaves the β-lactam ring. Mutations in penicillin-binding proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Penicillinase-sensitive penicillins
(Amoxicillin, ampicillin; aminopenicillins.)
- Mechanism
- Clinical Use

A

Same as penicillin. penicillinase sensitive. Also combine with clavulanic acid

“HHELPSS”
Extended-spectrum penicillin—H influenzae, H pylori, E coli, Listeria monocytogenes, Proteus mirabilis, Salmonella, Shigella, enterococci.

*AmOxicillin has greater Oral bioavailability than ampicillin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Penicillinase-sensitive penicillins

  • Adverse effects
  • Resistance
A

Hypersensitivity reactions, rash, pseudomembranous colitis.

Penicillinase (a type of β-lactamase) cleaves β-lactam ring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q 
Penicillinase-resistant penicillins
(Dicloxacillin, nafcillin, oxacillin.)
- Mechanism
- Clinical Use
- Adverse effects
- Resistance
A

Same as penicillin.

S aureus (except MRSA).

Hypersensitivity reactions, interstitial nephritis.

MRSA has altered penicillin-binding protein target site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q 
Antipseudomonal penicillins
(Piperacillin, ticarcillin)
- Mechanism
- Clinical Use
- Adverse effects
A

Same as penicillin

Pseudomonas spp. and gram ⊝ rods.

Hypersensitivity reactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

β-lactamase inhibitors

A

CAST.

Clavulanic acid, Avibactam, Sulbactam, Tazobactam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cephalosporins

  • Mechanism
  • Organisms not covered
  • Adverse effects
  • Resistance
A

β-lactam drugs that inhibit cell wall synthesis

LAME:
Listeria, Atypicals (Chlamydia, Mycoplasma), MRSA, and Enterococci.

Hypersensitivity reactions, autoimmune hemolytic anemia, disulfiram-like reaction, vitamin K deficiency. Low rate of crossreactivity even in penicillin-allergic patients.  nephrotoxicity of aminoglycosides.

Inactivated by cephalosporinases. Structural change in penicillinbinding proteins (transpeptidases).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cephalosporins 1st Generation

  • Names
  • Clinical use
A

cefazolin, cephalexin

PEcK.
gram ⊕ cocci, Proteus mirabilis, E coli, Klebsiella
pneumoniae. Cefazolin used prior to surgery to
prevent S aureus wound infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cephalosporins 2nd Generation

  • Names
  • Clinical use
A

cefaclor, cefoxitin, cefuroxime, cefotetan

HENS PEcK.
gram ⊕ cocci, H influenzae, Enterobacter aerogenes, Neisseria spp., Serratia marcescens, Proteus mirabilis, E coli, Klebsiella pneumoniae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cephalosporins 3rd Generation

  • Names
  • Clinical use
A

ceftriaxone, cefotaxime, cefpodoxime, ceftazidime

serious gram ⊝ infections resistant to other β-lactams.
Ceftriaxone—meningitis, gonorrhea, disseminated Lyme disease.
Ceftazidime—Pseudomonas.

*Can cross blood-brain barrier.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cephalosporins 4th Generation

  • Names
  • Clinical use
A

Cefepime

gram ⊝ organisms, with activity against Pseudomonas and gram ⊕ organisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cephalosporins 5th Generation

  • Names
  • Clinical use
A

Ceftaroline

broad gram ⊕ and gram ⊝ organism coverage;

unlike 1st–4th generation cephalosporins, ceftaroline covers Listeria, MRSA, and Enterococcus faecalis—
does not cover Pseudomonas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbapenems

  • Names
  • Mechanism
A

DIME
Doripenem, Imipenem, Meropenem, Ertapenem

Imipenem is a broad-spectrum, β-lactamase– resistant carbapenem. Always administered with cilastatin (inhibitor of renal dehydropeptidase I)

Newer carbapenems include ertapenem (limited
Pseudomonas coverage) and doripenem.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Carbapenems

  • Clinical use
  • Adverse effects
A

Gram ⊕ cocci, gram ⊝ rods, and anaerobes. limit use to life-threatening infections or after other drugs have failed.

Meropenem has a  risk of seizures and is stable to
dehydropeptidase I.

GI distress, rash, and CNS toxicity (seizures) at high plasma levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Monobactams (Aztreonam)

  • Mechanism
  • Clinical use
  • Adverse effects
A

Less susceptible to β-lactamases. Synergistic with aminoglycosides. No cross-allergenicity with penicillins.

Gram ⊝ rods only—no activity against gram ⊕ rods or anaerobes. For penicillin-allergic patients and those with renal insufficiency who cannot tolerate aminoglycosides.

Usually nontoxic; occasional GI upset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Vancomycin

  • Mechanism
  • Clinical use
A

Inhibits cell wall peptidoglycan formation by binding D-Ala-D-Ala portion of cell wall precursors. Bactericidal against most bacteria (bacteriostatic against C difficile).

Gram ⊕ bugs only—serious, multidrug-resistant organisms, including MRSA, S epidermidis, sensitive Enterococcus species, and Clostridium difficile (oral dose for pseudomembranous colitis).

19
Q

Vancomycin

  • Adverse effects
  • Resistance
A

NOT
Nephrotoxicity, Ototoxicity, Thrombophlebitis, diffuse flushing—red man syndrome (largely preventable by pretreatment with antihistamines and slow infusion rate), drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).

(eg, Enterococcus) via amino acid modification of D-Ala-D-Ala to D-Ala-D-Lac.

20
Q

Protein synthesis inhibitors

A

All are bacteriostatic, except aminoglycosides
(bactericidal) and linezolid (variable).

“Buy AT 30, CCEL (sell) at 50.”

30S inhibitors
Aminoglycosides
Tetracyclines

50S inhibitors
Chloramphenicol, Clindamycin
Erythromycin (macrolides)
Linezolid

21
Q

Aminoglycosides

  • Names
  • Clinical uses
A

GNATS: Gentamicin, Neomycin, Amikacin, Tobramycin, Streptomycin.

*Require O2 for uptake; therefore ineffective against anaerobes.

Severe gram ⊝ rod infections. Synergistic with β-lactam antibiotics. Neomycin for bowel surgery.

22
Q

Aminoglycosides

  • Adverse effects
  • Resistance
A

Nephrotoxicity, Neuromuscular blockade, Ototoxicity (especially when used with loop diuretics). Teratogen.

Bacterial transferase enzymes inactivate the drug by acetylation, phosphorylation, or adenylation.

23
Q

Tetracyclines

  • Names
  • Characteristics
  • Clinical uses
A

Tetracycline, doxycycline, minocycline.

Limited CNS penetration. Doxycycline is fecally eliminated and can be used in patients with renal failure. Do not take
tetracyclines with milk (Ca2+), antacids (Ca2+ or Mg2+), or iron-containing preparations because divalent cations inhibit drugs’ absorption in the gut.

Borrelia burgdorferi, M pneumoniae. Drugs’ ability to accumulate intracellularly makes them very effective against Rickettsia and Chlamydia. Also used to treat acne. Doxycycline effective against MRSA.

24
Q

Tetracyclines

  • Adverse effects
  • Resistance
A

GI distress, discoloration of teeth and inhibition of bone growth in children, photosensitivity. Contraindicated in pregnancy.

uptake or  efflux out of bacterial cells by plasmid-encoded transport pumps.

25
Q

Glycylcyclines (Tigecycline)

  • Mechanism
  • Clinical use
  • Adverse effects
A

Binds to 30S. Generally bacteriostatic.

Broad-spectrum anaerobic, gram ⊝, and gram ⊕ coverage. Multidrug-resistant organisms (MRSA, VRE) or infections requiring deep tissue penetration.

GI symptoms: nausea, vomiting.

26
Q

Chloramphenicol

  • Clinical use
  • Adverse effects
  • Resistance
A

Meningitis (Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae) and rickettsial diseases. Limited use due to toxicity

Anemia (dose dependent), aplastic anemia (dose independent), gray baby syndrome (in premature
infants because they lack liver UDP glucuronosyltransferase).

Plasmid-encoded acetyltransferase inactivates the drug.

27
Q

Clindamycin

  • Clinical use
  • Adverse effects
A

Anaerobic infections (eg, Bacteroides spp., Clostridium perfringens) in aspiration pneumonia, lung abscesses, and oral infections. Also effective against invasive group A streptococcal infection.

*Treats anaerobic infections above the diaphragm vs metronidazole below

Pseudomembranous colitis (C difficile overgrowth), fever, diarrhea.

28
Q

Oxazolidinones (Linezolid)

  • Clinical use
  • Adverse effects
  • Resistance
A

Gram ⊕ species including MRSA and VRE.

Bone marrow suppression (especially thrombocytopenia), peripheral neuropathy, serotonin syndrome.

Point mutation of ribosomal RNA.

29
Q

Macrolides (Azithromycin, clarithromycin, erythromycin)

  • Clinical use
  • Adverse effects
  • Resistance
A

Atypical pneumonias (Mycoplasma, Chlamydia, Legionella), STIs (Chlamydia), gram ⊕ cocci (streptococcal infections in patients allergic to penicillin), and B pertussis.

MACRO: gastrointestinal Motility issues, Arrhythmia caused by prolonged QT interval, acute Cholestatic hepatitis, Rash, eOsinophilia.

Methylation of 23S rRNA-binding site prevents binding of drug.

30
Q

Polymyxins (Colistin (polymyxin E), polymyxin B)

  • Mechanism
  • Clinical use
  • Adverse effects
A

Cation polypeptides that bind to phospholipids on cell membrane of gram ⊝ bacteria. Disrupt cell membrane integrity Ž leakage of cellular components Ž cell death.

Salvage therapy for multidrug-resistant gram ⊝ bacteria (eg, P aeruginosa, E coli, K pneumoniae). Polymyxin B is a component of a triple antibiotic ointment used for superficial skin infections.

Nephrotoxicity, neurotoxicity (eg, slurred speech, weakness, paresthesias), respiratory failure.

31
Q

Sulfonamides

  • Names
  • Mechanism
  • Clinical use
A

Sulfamethoxazole (SMX), sulfisoxazole, sulfadiazine.

Inhibit dihydropteroate synthase, thus inhibiting folate synthesis. Bacteriostatic (bactericidal when combined with trimethoprim).

Gram ⊕, gram ⊝, Nocardia. TMP-SMX for simple UTI.

32
Q

Sulfonamides

  • Adverse effects
  • Resistance
A

Hypersensitivity reactions, hemolysis if G6PD deficient, nephrotoxicity (tubulointerstitial nephritis), photosensitivity, Stevens-Johnson syndrome, kernicterus in infants, displace
other drugs from albumin (eg, warfarin).

Altered enzyme (bacterial dihydropteroate synthase),  Lower uptake, or  High PABA synthesis.

33
Q

Dapsone

  • Mechanism
  • Clinical use
  • Adverse effects
A

Similar to sulfonamides

Leprosy (lepromatous and tuberculoid), Pneumocystis jirovecii prophylaxis.

Hemolysis if G6PD deficient, methemoglobinemia.

34
Q

Trimethoprim

A

Inhibits bacterial dihydrofolate reductase. Bacteriostatic

Combination used for UTIs, Shigella, Salmonella, Pneumocystis jirovecii pneumonia treatment and prophylaxis, toxoplasmosis prophylaxis.

Megaloblastic anemia, leukopenia, granulocytopenia, which may be avoided with coadministration of folinic acid. TMP Treats Marrow Poorly.

35
Q

Fluoroquinolones

  • Names
  • Mechanism
  • Clinical use
A

Ciprofloxacin, enoxacin, norfloxacin, ofloxacin; respiratory fluoroquinolones—gemifloxacin, levofloxacin, moxifloxacin.

Inhibit prokaryotic enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. Bactericidal. Must not be taken with antacids.

Gram ⊝ rods of urinary and GI tracts (including Pseudomonas), some gram ⊕ organisms, otitis externa.

36
Q

Fluoroquinolones

  • Adverse effects
  • Resistance
A

GI upset, superinfections, skin rashes, headache, dizziness. Less commonly, can cause leg cramps and myalgias.

Contraindicated in pregnant women, nursing mothers, and children < 18 years old due to possible damage to cartilage. Some may prolong QT interval.

May cause tendonitis or tendon rupture in people > 60 years old and in patients taking prednisone. Ciprofloxacin inhibits cytochrome P-450.

37
Q

Fluoroquinolones

- Resistance

A

Chromosome-encoded mutation in DNA gyrase, plasmid-mediated resistance, efflux pumps.

38
Q

Daptomycin

  • Mechanism
  • Clinical use
  • Adverse effects
A

Lipopeptide that disrupts cell membranes of gram ⊕ cocci by creating transmembrane channels.

S aureus skin infections (especially MRSA), bacteremia, endocarditis, VRE. Not used for pneumonia (avidly binds to and is inactivated by surfactant).

Myopathy, rhabdomyolysis.

39
Q

Metronidazole

  • Mechanism
  • Clinical use
  • Adverse effects
A

Forms toxic free radical metabolites in the bacterial cell that damage DNA. Bactericidal, antiprotozoal.

GET GAP on the METRO: Giardia, Entamoeba, Trichomonas, Gardnerella vaginalis, Anaerobes (Bacteroides, C difficile).

Disulfiram-like reaction (severe flushing, tachycardia, hypotension) with alcohol; headache, metallic taste.

40
Q

Antimicrobial prophylaxis

  1. High risk for endocarditis and undergoing surgical or dental procedures
  2. Exposure to gonorrhea
  3. History of recurrent UTIs
  4. Exposure to meningococcal infection
  5. Pregnant woman carrying group B strep
A
  1. Amoxicillin
  2. Ceftriaxone
  3. TMP-SMX
  4. Ceftriaxone, ciprofloxacin, or rifampin
  5. Intrapartum penicillin G or ampicillin
41
Q

Antimicrobial prophylaxis

  1. Prevention of gonococcal conjunctivitis in newborn
  2. Prevention of postsurgical infection due to S aureus
  3. Prophylaxis of strep pharyngitis in child with prior rheumatic fever.
  4. Exposure to syphilis
A
  1. Erythromycin ointment on eyes
  2. Cefazolin
  3. Benzathine penicillin G or oral penicillin V
  4. Benzathine penicillin G
42
Q

Treatment of highly resistant bacteria

  • MRSA:
  • VRE:
  • Multidrug-resistant P aeruginosa, multidrug-resistant Acinetobacter baumannii:
A

vancomycin, daptomycin, linezolid, tigecycline, ceftaroline, doxycycline.

linezolid and streptogramins (quinupristin, dalfopristin).

polymyxins B and E (colistin).

43
Q

Prophylaxis in HIV patients

  • CD4 < 200 cells/mm3
  • CD4 < 100 cells/mm3
  • CD4 < 50 cells/mm3
A
  • TMP-SMX Pneumocystis pneumonia
  • TMP-SMX Pneumocystis pneumonia and toxoplasmosis
  • Azithromycin or clarithromycin Mycobacterium avium complex.

USMLE 1 (73 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions